Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04969094 · ClinicalTrials.gov registry record · NA

Reducing Fall Risk With NMES

A NA study of Falls, sponsored by VA Office of Research and Development.

Active
Registry status
NA
Development phase
81
Enrollment target
1
Study location

NCT04969094: Active NA study of Falls, sponsored by VA Office of Research and Development.

NCT04969094 is a NA study of Falls that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 81 participants, below the 219-participant average among 7 other Falls trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04969094, a NA study of Falls, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
81 participants
Enrollment target
1
Study location

Study Summary

Falls are dangerous leading to injuries, hospital admissions and even death. Fall prevention is a priority but effective programs only reduce falls by 30%. Weak hip muscles may be one reasons individuals experience a loss of balance. However individuals who have weak hip muscles may be unable to exercise at sufficient intensities to improve their hip muscle strength. The purpose of this study is to utilize a common physical therapy method, neuromuscular electrical stimulation (NMES), on the hip muscles to improve hip muscle strength and improve balance. The new program focuses on using NMES during a resistance training program along with exercise to improve standing balance, walking and stepping over objects. This study will test the additive effect of NMES applied to the hip muscles during a balance and strengthening program to improve balance and mobility, and ultimately reduce the risk of falls in older Veterans at high risk for falls.

Primary Outcome

The four-square step test will be used as a measure of balance. The change in the amount of time it takes to complete the four-square step test comparing pre and post-intervention.

Conditions Studied

Interventions

  • OTHER Neuromuscular electrical stimulation (NMES)
  • OTHER Multi-Modality Balance Intervention (MMBI)

Study Locations (1)

Maryland

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2022-01-04
Est. Completion 2027-01-29
Phase NA
VA Office of Research and Development

1,668 total trials

What the registry record for NCT04969094 still lists

NCT04969094 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 219-participant average among 7 other Falls trials with a reported enrollment target (63% lower).

The record links to 1 condition, with Falls appearing as the primary indexed condition, and to 2 interventions - of which Neuromuscular electrical stimulation (NMES) is the first listed.

NCT04969094 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04969094 about?

NCT04969094 is a clinical study titled "Reducing Fall Risk With NMES". Falls are dangerous leading to injuries, hospital admissions and even death. Fall prevention is a priority but effective programs only reduce falls by 30%. Weak hip muscles may be one reasons individuals experience a loss of balance. However individuals who have weak hip muscles may be unable to exe...

What is the current status of trial NCT04969094?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 81 participants. The study started on 2022-01-04. Estimated completion is 2027-01-29.

What conditions does trial NCT04969094 study?

This clinical trial studies the following conditions: Falls.

What interventions are being tested in trial NCT04969094?

The interventions under investigation include: Neuromuscular electrical stimulation (NMES) (OTHER), Multi-Modality Balance Intervention (MMBI) (OTHER).

Who is sponsoring clinical trial NCT04969094?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04969094 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Falls

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04966481 · 81 participants · Phase 3

    Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

  • NCT05109429 · 81 participants · NA

    Developing a Clinical Outcome Assessment for Opioid Craving

  • NCT05112601 · 81 participants · Phase 2

    Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • NCT05305911 · 81 participants · Phase 2

    Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04969094, the US trial registry maintained by the National Library of Medicine. NCT04969094 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.